Family summary
Historical shortage references are available across related Dantrolene sodium presentations from multiple manufacturers.
- 0 current shortage context pages.
- 3 historical shortage context pages.
- 3 manufacturers represented.
Public shortage context is available across 3 visible exact NDC pages for this generic family.
This family page is organized from FDA/openFDA shortage records and other publicly available source material, then indexed by generic drug name, manufacturer, NDC, and package details for faster browsing.
Historical shortage references are available across related Dantrolene sodium presentations from multiple manufacturers.
These exact presentation links are useful for brand-name, size, and NDC-specific searches related to this shortage family.
Use the exact NDC page when your team needs package-level product details, public shortage references, and the strongest route into RFQ and sourcing workflows. These links open directly to the Drug Shortage Information section for each product page.
| Drug Name | NDC 11 | Manufacturer | Shortage Context |
|---|---|---|---|
| dantrolene sodium 250 mg / 5mL Injection 20 mL (Ryanodex, dantrolene sodium)PRN Watchlist NDC 42367-0540-32 | 1 Vial | Eagle Pharmaceuticals, Inc. | 42367-0540-32 | Eagle Pharmaceuticals, Inc. | Historical shortage context |
| dantrolene sodium 20 mg / 60mL Injection 60 mL (Dantrium) NDC 42023-0123-06 | 6 Vial | Par Health USA, LLC | 42023-0123-06 | Par Health USA, LLC | Historical shortage context |
| dantrolene sodium 20 mg / 60mL Injection 60 mL (Revonto) NDC 78670-0003-67 | 6 Vial, Glass | Uswm, Llc | 78670-0003-67 | Uswm, Llc | Historical shortage context |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.